{{Chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 461095771
| ImageFile = Esuprone.svg
| IUPACName = 3,4-Dimethyl-2-oxo-2''H''-chromen-7-yl ethanesulfonate
| OtherNames =
|Section1={{Chembox Identifiers
| CASNo_Ref = {{cascite|changed|??}}
| CASNo = 91406-11-0
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = K7EB9E48ZE
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 18504
| PubChem = 65827
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 59239
| SMILES = O=S(=O)(Oc2ccc\1c(OC(=O)/C(=C/1C)C)c2)CC
| InChI = 1/C13H14O5S/c1-4-19(15,16)18-10-5-6-11-8(2)9(3)13(14)17-12(11)7-10/h5-7H,4H2,1-3H3
| InChIKey = CHDGAVDQRSPBTA-UHFFFAOYAR
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H14O5S/c1-4-19(15,16)18-10-5-6-11-8(2)9(3)13(14)17-12(11)7-10/h5-7H,4H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CHDGAVDQRSPBTA-UHFFFAOYSA-N
  }}
|Section2={{Chembox Properties
| Properties_ref = <ref name=Ganellin>{{cite book|last=Ganellin|first=C. R|title=Dictionary of pharmacological agents|year=1996|publisher=CRC Press|isbn=978-0-412-46630-4|pages=1056}}</ref>
| C=13 | H=14 | O=5 | S=1
| Appearance =
| Density =
| MeltingPt =
| BoilingPt =
| Solubility =
  }}
|Section3={{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
  }}
}}

'''Esuprone''' is an experimental drug candidate being investigated as an [[antidepressant]].<ref name=Attila>{{cite book|last=Vértes|first=Attila|title=Handbook of nuclear chemistry|year=2003|publisher=Springer|isbn=978-1-4020-1316-4|pages=155}}</ref>  It acts as an [[monoamine oxidase A]] (MAO-A) inhibitor.<ref>{{cite journal | pmid = 9174681 | year = 1997 | last1 = Bergström | first1 = M | last2 = Westerberg | first2 = G | last3 = Németh | first3 = G | last4 = Traut | first4 = M | last5 = Gross | first5 = G | last6 = Greger | first6 = G | last7 = Müller-Peltzer | first7 = H | last8 = Safer | first8 = A | last9 = Eckernäs | first9 = SA | last10 = Grahnér | first10 = A | last11 = Långström | first11 = B | title = MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: In vivo studies with positron emission tomography | volume = 52 | issue = 2 | pages = 121–8 | journal = European journal of clinical pharmacology | display-authors = 8 | doi=10.1007/s002280050260}}</ref>

==References==
{{Reflist}}


{{Monoamine metabolism modulators}}

[[Category:Antidepressants]]
[[Category:Sulfonate esters]]
[[Category:Coumarins]]